Hamid Jafari

Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication

Radboud J. Duintjer Tebbens, Mark A. Pallansch, Olen M. Kew et al. · Risk Analysis · 2006 · 172 citations · Full text

Virus Epidemiology, Epidemiological Dynamic, Eradication Of Disease +18

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

Roland W. Sutter, T. Jacob John, Hemant Jain et al. · The Lancet · 2010 · 142 citations

Vaccination, Cell-based Vaccine Production, Vaccine Safety +9

Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial

Concepción F. Estívariz, Hamid Jafari, Roland W. Sutter et al. · The Lancet Infectious Diseases · 2011 · 98 citations

Vaccination, Vaccine Safety, Vaccinology +11

Possible eradication of wild poliovirus type 3--worldwide, 2012.

Olen M. Kew, Stephen L. Cochi, Hamid Jafari et al. · PubMed · 2014 · 86 citations

World Health Organization, Virus Epidemiology, Regional Eradication +18

The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses

Kimberly M. Thompson, Radboud J. Duintjer Tebbens, Mark A. Pallansch et al. · American Journal of Public Health · 2008 · 81 citations · Full text